These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23812939)

  • 41. Relation between NT-proBNP levels, iron overload, and early stage of myocardial dysfunction in β-thalassemia major patients.
    Balkan C; Tuluce SY; Basol G; Tuluce K; Ay Y; Karapinar DY; Gurgun C; Bayindir O; Kavakli K
    Echocardiography; 2012 Mar; 29(3):318-25. PubMed ID: 22066516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart rate variability in β-thalassaemia major with or without cardiac siderosis.
    Alp A; Ozdogan O; Guloglu CC; Turker M; Atabay B
    Cardiol Young; 2014 Apr; 24(2):263-7. PubMed ID: 23402458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
    Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
    Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
    Chaosuwannakit N; Makarawate P; Wanitpongpun C
    Tomography; 2021 Apr; 7(2):130-138. PubMed ID: 33919601
    [No Abstract]   [Full Text] [Related]  

  • 45. Detection of cardiac iron overload with native magnetic resonance T1 and T2 mapping in patients with thalassemia.
    Krittayaphong R; Zhang S; Saiviroonporn P; Viprakasit V; Tanapibunpon P; Komoltri C; Wangworatrakul W
    Int J Cardiol; 2017 Dec; 248():421-426. PubMed ID: 28688717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left ventricular systolic dyssynchrony index and endothelial dysfunction parameters as subclinical predictors of cardiovascular involvement in patients with beta-thalassemia major.
    Solmaz H; Cabuk AK; Altin Z; Albudak Ozcan E; Ozdogan O
    Echocardiography; 2021 Jun; 38(6):825-833. PubMed ID: 33945174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.
    Pepe A; Positano V; Santarelli MF; Sorrentino F; Cracolici E; De Marchi D; Maggio A; Midiri M; Landini L; Lombardi M
    J Magn Reson Imaging; 2006 May; 23(5):662-8. PubMed ID: 16568436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of left ventricular functions and myocardial iron load with tissue Doppler and speckle tracking echocardiography and T2* MRI in patients with β-thalassemia major.
    Ari ME; Ekici F; Çetin İİ; Tavil EB; Yaralı N; Işık P; Hazırolan T; Tunç B
    Echocardiography; 2017 Mar; 34(3):383-389. PubMed ID: 28139073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automated truncation method for myocardial T2* measurement in thalassemia.
    He T; Zhang J; Carpenter JP; Feng Y; Smith GC; Pennell DJ; Firmin DN
    J Magn Reson Imaging; 2013 Feb; 37(2):479-83. PubMed ID: 22927335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.
    Pepe A; Meloni A; Capra M; Cianciulli P; Prossomariti L; Malaventura C; Putti MC; Lippi A; Romeo MA; Bisconte MG; Filosa A; Caruso V; Quarta A; Pitrolo L; Missere M; Midiri M; Rossi G; Positano V; Lombardi M; Maggio A
    Haematologica; 2011 Jan; 96(1):41-7. PubMed ID: 20884710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy.
    Meloni A; Positano V; Ruffo GB; Spasiano A; D'Ascola DG; Peluso A; Keilberg P; Restaino G; Valeri G; Renne S; Midiri M; Pepe A
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):325-34. PubMed ID: 25246505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia major.
    Pennell DJ; Porter JB; Cappellini MD; Chan LL; El-Beshlawy A; Aydinok Y; Ibrahim H; Li CK; Viprakasit V; Elalfy MS; Kattamis A; Smith G; Habr D; Domokos G; Roubert B; Taher A
    Haematologica; 2012 Jun; 97(6):842-8. PubMed ID: 22271905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The correlation between cardiac magnetic resonance T2* and left ventricular global longitudinal strain in people with β-thalassemia.
    Parsaee M; Akiash N; Azarkeivan A; Alizadeh Sani Z; Amin A; Pazoki M; Samiei N; Jalili MA; Adel MH; Rezaian N
    Echocardiography; 2018 Apr; 35(4):438-444. PubMed ID: 29399871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events.
    Patton N; Brown G; Leung M; Bavishi K; Taylor J; Lloyd J; Lee SH; Tay L; Worthley S
    Intern Med J; 2010 Jun; 40(6):419-26. PubMed ID: 19460052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiac Iron Overload by MRI in Children With B-Thalassemia Major and its Correlation With Cardiac Function by Echocardiography.
    El-Shanshory M; Tolba O; El-Shafiey R; Elgamasy M; Hablas N; Mawlana W
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):398-402. PubMed ID: 32251156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of electrocardiography, echocardiography and cardiac T2* for cardiac complications in beta thalassemia major.
    Ersoy Dursun F; Açıksarı G; Özkök S; İncealtın O
    Int J Cardiovasc Imaging; 2022 Mar; 38(3):533-542. PubMed ID: 34623560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia.
    Silvilairat S; Charoenkwan P; Saekho S; Tantiworawit A; Phrommintikul A; Srichairatanakool S; Chattipakorn N
    PLoS One; 2016; 11(10):e0164300. PubMed ID: 27737009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calibration of myocardial T2 and T1 against iron concentration.
    Carpenter JP; He T; Kirk P; Roughton M; Anderson LJ; de Noronha SV; Baksi AJ; Sheppard MN; Porter JB; Walker JM; Wood JC; Forni G; Catani G; Matta G; Fucharoen S; Fleming A; House M; Black G; Firmin DN; St Pierre TG; Pennell DJ
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):62. PubMed ID: 25158620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up.
    Daar S; Al Khabori M; Al Rahbi S; Hassan M; El Tigani A; Pennell DJ
    Ann Hematol; 2020 Sep; 99(9):2009-2017. PubMed ID: 32556452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.